Antiseizure medications for neonates with seizures

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess whether any anti-seizure medication (ASM) is more or less effective than an alternative ASM (both ASMs used as first-, second- or third-line treatment) in achieving seizure control and improving neurodevelopmental outcomes in neonates with seizures. We will analyse EEG-confirmed seizures and clinically-diagnosed seizures separately. To assess maintenance therapy with ASM compared to no maintenance therapy after achieving seizure control. We will analyse EEG-confirmed seizures and clinically-diagnosed seizures separately. To assess any ASM treatment compared to no ASM treatment for clinically-diagnosed or only-electrographic seizures.

Cite

CITATION STYLE

APA

Abiramalatha, T., Thanigainathan, S., Ramaswamy, V. V., Pressler, R., Brigo, F., & Hartmann, H. (2022, March 25). Antiseizure medications for neonates with seizures. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD014967

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free